Training activity information
Details
Interpret and report on a range of genetic testing in germline cancer susceptibility, to include:
- Breast/ovarian,
- Lynch syndrome
- FAP
Type
Entrustable training activity (ETA)
Evidence requirements
Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion.
Reflection at multiple timepoints on the trainee learning journey for this activity.
Considerations
- Interpretation of results including diagnostic and treatment recommendations
- Evidence base, literature and online databases
- Integrated reporting
- Local format for reporting
- Best practice guidance
- Local and national guidance
- Implications and recommendations
- Sensitivity and limitations
- Quality control; IQC, EQA
- Nomenclature, correct scientific and clinical terminology
- Local SOPs
- Confidentiality and information governance
- Communication of complex scientific information to clinicians and patients
- Limitations associated with the test performed
- Implications for the wider family
- Reporting considerations for indirect tests
- Interplay of IHC, microsatellite instability testing and BRAF analysis in Lynch syndrome screening
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 5 |
Outcome
Analyse, interpret and report tests for patients referred with germline cancer. |